Collegium Pharmaceutical, Inc. (COLL)

49.56 +0.71 (+1.45%) USD  |  NASDAQ  |  Dec 24, 12:59
49.56 0.00 (0.00%) After-Hours: 13:59
More

Collegium Pharmaceutical SG&A Expense (TTM): 280.25M for Sept. 30, 2025

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for COLL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Catalyst Pharmaceuticals, Inc. 162.44M
Alnylam Pharmaceuticals, Inc. 1.181B
Altimmune, Inc. 22.68M
Vertex Pharmaceuticals, Inc. 1.644B
Viking Therapeutics, Inc. 52.36M